To Create Wealth
Invest In Health
Includes manufacturing, extraction, pricessing, purification and packaging Eg – Sun Pharma
Includes manufacturing, extraction, pricessing, purification and packaging Ex- Valiant organics
Includes healthcare centres, district hospital, general hospital & nursing homes. Eg – Apollo Hospital
Includes businesses and laboratories with analytical or diagnostic services. Eg – Lal Path labs
Includes medical equipment and supplies. . Eg – Poly Medicure
Source/ Disclaimer:The sectors mentioned above are used to explain the concept and is for illustration purpose only and should not be used for development or implementation of an investment strategy. The stock may or may not be part of our portfolio/strategy/ schemes. It should not be construed as investment advice to any party.
Source: S&P BSE. Data as of 30-Jun-2022. Sectors – Basic Industry classification as per AMFI Industry Classification. The stocks/sectors mentioned above are used to explain the concept and is for illustration purpose only and should not be used for development or implementation of an investment strategy. The stock may or may not be part of our portfolio/strategy/ schemes. It should not be construed as investment advice to any party. Past performance may or may not be sustained in future.
To drive growth of high-end medical services
Pandemic accelerated insurance adoption
Becoming a preferred destination
![100%[2]FDI](assets/img/NFO/spbseheathcare/safe-deposit.png)
Becoming a preferred destination
To drive growth of high-end medical services
Pandemic accelerated insurance adoption
Becoming a preferred destination
Becoming a preferred destination
Source/Disclaimer:*100% FDI permitted under automatic route in the hospital sector. In the pharmaceutical sector, 100% FDI in green field projects and 74% in brownfield projects. The graphic is used to explain the concept and is for illustration purpose only and should not be used for development or implementation of an investment strategy.
Source/Disclaimer: spglobal.com; Performance as of close of 30-June-07 to 30-June-22. Performance results have many inherent limitations and no representation is being made that any investor will, or is likely to achieve. Past performance may or may not be sustained in future. The above graph is used to explain the concept and is for illustration purpose only and should not used for development or implementation of an investment strategy.
Investment ObjectiveThe investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by S&P BSE Healthcare TRI, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Minimum application amountOn Exchange :Investors can buy/sell units of the Scheme in round lot of 1 unit and in multiples thereafter.
Directly with Mutual Fund: Buy/sell units of the Scheme where the subscription / redemption amount is in excess of INR 25 Crs. However, the same limit is not applicable to Market makers.
Type of Scheme
An open ended fund replicating/tracking S&P BSE Healthcare Total Return Index
Exit LoadNIL
Date of Allotment29-Jul-2022
Fund ManagerMr. Swapnil Mayekar &
Mr. Abhiroop Mukherjee (debt component)
Indicative Total Expense ratioRegular- 0.20%
Benchmark & Riskometer Motilal Oswal S&P BSE Healthcare ETF (An open ended scheme replicating / tracking the S&P BSE Healthcare Total Return Index) BSE Scrip Code and NSE Symbol: The scheme is proposed to be listed on Bombay Stock Exchange Limited and National Stock Exchange of India Limited. Please note that the scrip code and NSE symbol will be generated post listing of the scheme.
